Canal Biosciences, Inc.
Last verified 2026-05-06. JSON
| Total raised | $2.3M |
|---|---|
| Latest round | Funding round, $2.3M, 2026-03-18 |
| Founded | 2024 |
| Headquarters | Lowell, MA |
| Industry | biotech |
| Stage | unknown |
| Website | canalbiosciences.com |
Canal Biosciences develops NGS library-prep technology through its TrueLink platform that preserves DNA template integrity. It serves genomics researchers and clinicians in sensitive applications like liquid biopsy and methylation. Its differentiator is a simultaneous dual-ligation workflow that avoids the DNA-rewriting errors of conventional end-repair.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2026-03-18 | Funding round | $2.3M | undisclosed |
Detected tech stack
Cloudflare, WordPress 6.9.4, Yoast SEO 25.9, Google Analytics, Google Tag Manager, Sassy Social Share 3.3.79, Slick, Swiper, jQuery Migrate 3.4.1, imagesLoaded 5.0.0, Elementor 3.34.1, PHP
Provenance
| Fact | Status | Basis |
|---|---|---|
| Funding round, $2.3M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Total raised $2.3M | sourced | SEC EDGAR named as publisher. Document, retrieved 2026-09-25. |
| Company existence | self-reported | canalbiosciences.com, read 2026-05-06 |
| Description | self-reported | canalbiosciences.com, read 2026-05-06 |
Change history
| Date | Fact | Change | Basis |
|---|---|---|---|
| 2026-09-25Latest round: seed, $2.3M, 2026-03-18 → Funding round, $2.3M, 2026-03-18, SEC EDGAR, document, retrieved 2026-09-25 | Latest round | seed, $2.3M, 2026-03-18 → Funding round, $2.3M, 2026-03-18 | SEC EDGAR, document, retrieved 2026-09-25 |
| 2026-09-25Round: attributed → sourced, SEC EDGAR, document, retrieved 2026-09-25 | Round | attributed → sourced | SEC EDGAR, document, retrieved 2026-09-25 |
Records begin 2026-09-24. All changes